13 studies were found.

1.		No longer recruiting	Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
2.		No longer recruiting	Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia Condition: recurrent childhood acute lymphoblastic leukemia
3.		No longer recruiting	Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma Condition: adult non-Hodgkin's lymphoma
4.		No longer recruiting	Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma Conditions: stage IV mantle cell lymphoma; stage II adult diffuse small cleaved cell lymphoma; stage IV diffuse small lymphocytic/marginal zone lymphoma; ...
5.		Recruiting	Combination Chemotherapy, Celecoxib, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer Conditions: adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
6.		No longer recruiting	Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent grade I follicular small cleaved cell lymphoma; ...
7.		Recruiting	Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma That Has Relapsed After High-Dose Chemotherapy and Autologous Stem Cell Transplantation Condition: adult non-Hodgkin's lymphoma
8.		Recruiting	Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Conditions: recurrent adult diffuse mixed cell lymphoma; recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma
9.		Recruiting	Rituximab and Carmustine, Cytarabine, Etoposide, and Melphalan Followed By Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Condition: adult non-Hodgkin's lymphoma
10.		No longer recruiting	Rituximab and Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
11.		Recruiting	Vaccine Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma Conditions: recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma
12.		No longer recruiting	Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma Condition: Lymphoma
13.		No longer recruiting	Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma Conditions: stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...